Aardvark Therapeutics appoints David Zhang to board of directors
Covered in this story
What has happened since
- Aardvark Therapeutics Inc is down 17.2% since this was published, 12 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AARD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Aardvark Therapeutics Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.